A Phase Ⅱ Study of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal Dysfunction

NCT06782594 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Gastrointestinal Dysfunction

Interventions

DRUG: Mosapride Citrate Injection(high)
DRUG: Mosapride Citrate Injection(low)
DRUG: Placebo

Sponsor

Shandong New Time Pharmaceutical Co., LTD